alexa Photodynamic Vaccination: Novel Strategies Of Vaccine Delivery By Intraphagolysosomal Parasites And Their Oxidative Inactivation For Safe And Effective Applications
ISSN: 2155-9597

Journal of Bacteriology & Parasitology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

2nd International Congress on Bacteriology & Infectious Diseases
November 17-19, 2014 DoubleTree by Hilton Hotel Chicago-North Shore, USA

Kwang Poo Chang, Bala Kolli, Pankaj Tripathi, Dennis K P Ng, Chin Shen Chang, Saad Alkahtani4, Ahmed Al-Qahtani, Camila I de Oliveira, Sayonara Mello, Laura Manna, Angelo Elio Gravino, Jonathan F Head, Robert L Elliott and Ramesh Babu Batchu
ScientificTracks Abstracts: J Bacteriol Parasitol
DOI: 10.4172/2155-9597.S1.006
Leishmania (trypanosomatid protozoa) have a number of advantages, which distinguish them favorably from other microbes/particles to serve as a universal vaccine carrier. Biotechnology is well-established to produce transgenic Leishmania for expressing peptide vaccines. Multiple vaccines can be expressed episomally at high capacity via its eukaryotic mechanisms of protein translation and post-translational modifications, e. g. N-glycosylation. Technology is also available to grow Leishmania in serum-free/autoclavable or chemically defined media that is expandable to industrial scale cost-effectively. The major attributes of Leishmania for vaccine delivery are their surface glyco-conjugates responsible for the following properties: Protection of Leishmania, hence their expressed vaccines from losses to the activities of humoral factors in the mammalian hosts; Targeting the vaccines to the phagosome-lysosome vacuolar system of macrophages and dendritic cells - a desirable destination for effective vaccine processing and presentation; and Serving as potential adjuvants for the natural vaccines to elicit the lasting immunity seen after spontaneous/therapeutic cure of human leishmaniasis. Significantly, the surface glycoconjugates retain these functional activities when Leishmania are photo-inactivated with reactive oxygen species (ROS). Photo-inactivation of Leishmania with ROS eliminates their immunosuppressive activities and releases vaccines in macrophages. A complete loss of Leishmania viability in vitro and in vivo ensues, especially when doubly photo-inactivated for cytosolic accumulation of uroporphyrin and endosomal uptake of exogenous cationic phthalocyanines. The delivery of ovalbumin (OVA) as a surrogate vaccine by such photo-inactivated Leishmania is more effective than by conventional methods in activation of OVA peptide-specific CD4+ and CD8+ T cells. Previously, evidence has been presented, showing that photodynamic vaccination of animals with Leishmania so inactivated produced effective immunity that is adaptively transferable to na?ve individuals against experimental leishmaniasis. Immunotherapy of canine leishmaniasis with photoinactivated Leishmania produced encouraging preliminary results. Work is also underway to use such carrier to deliver add-on vaccines against other infectious and malignant diseases.
image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version